Speaker Name : Ravi Kiron, Ph.D., MBA
Company : Adjuvant Global Advisors, LLC
Title : Managing Director

Dr. Ravi Kiron has 23 years of experience in the pharmaceutical and healthcare industry and is well versed in all aspects of drug discovery and delivery; pre-clinical and early clinical drug development; bioinformatics and database management; M&A, investment due-diligence, and alliance management. In a consulting practice for the last few years, he has provided business development and strategic advisory, regarding pipeline challenges and asset sales of discovery and development programs, IP and manufacturing plants, to clients in the pharma and biotech space, and Private Equity and Hedge Fund firms in the US/EU and Asia.

Prior to Adjuvant, Dr. Kiron was the COO at LifeTech Innovations (LTI), a Business Development and Strategic Advisory consulting firm. As part of LTI, Dr. Kiron provided guidance to a number of biotech, private equity firms and hedge funds for strategy issues and capital raise needs. Dr. Kiron is also a cofounder of C2N Diagnostics, LLC that is in the CNS diagnostics arena. Before LTI, he was at Johnson & Johnson/ALZA Corporation, responsible for drug delivery technology & research strategy planning, in- and out-licensing, M&A and intellectual property management. Dr. Kiron spent 14 years at Pfizer Global R&D in the departments of Strategic Alliances, Project Management and Cardiovascular Drug Discovery. While at Pfizer, he was a primary architect of many US/non-US based partnerships, an acquisition/integration team member for Pfizer’s purchase of Warner-Lambert and Pharmacia Corporation, and other biotechs. Dr. Kiron obtained experience in exploratory drug development as the project champion at Pfizer that led to the IND filing of Tarceva�, now used for treatment of multiple malignancies. He led drug discovery research teams in cardiovascular and metabolic disorders. Prior to Pfizer, Dr. Kiron was a biochemistry and medicine faculty member at Cornell University Medical Center in New York.

He holds a BSc in Chemistry and an MSc in Microbiology through colleges in Goa from Bombay University, India. He also earned a PhD in Biochemistry from the Indian Institute of Science in Bangalore, India and an MBA from Rensselaer in Hartford, Connecticut.